Strategy Asset Managers LLC Indaptus Therapeutics, Inc. Transaction History
Strategy Asset Managers LLC
- $465 Million
- Q1 2024
A detailed history of Strategy Asset Managers LLC transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Strategy Asset Managers LLC holds 45,336 shares of INDP stock, worth $98,832. This represents 0.02% of its overall portfolio holdings.
Number of Shares
45,336
Previous 45,336
-0.0%
Holding current value
$98,832
Previous $79,000
27.85%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding INDP
# of Institutions
18Shares Held
588KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$558,6570.0% of portfolio
-
Investment House LLC Las Vegas, NV102KShares$223,3120.01% of portfolio
-
Geode Capital Management, LLC Boston, MA54.8KShares$119,3920.0% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ44.1KShares$96,2360.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny26.1KShares$56,8980.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $18M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...